| CAS No. | 1263774-59-9 |
|---|---|
| MDL No. | N/A |
| MF | C16H18N6O |
| MW | 310.35 |
| InChI Key | LOWWYYZBZNSPDT-ZBEGNZNMSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | 99% | $79 | In Stock | |
| 2 mg | 99% | $130 | In Stock | |
| 5 mg | 99% | $231 | In Stock | |
| 10 mg | 99% | $393 | In Stock | |
| 25 mg | 99% | $781 | In Stock | |
| 50 mg | 99% | $1170 | In Stock | |
| 100 mg | 99% | $1752 | In Stock | |
| 250 mg | 99% | $2977 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Delgocitinib is a 7H-pyrrolo[2,3-d]pyrimidine substituted at position 4 with a (3S,4R)-1-(cyanoacetyl)-3-methyl-1,6-diazaspiro[3.4]octan-6-yl group. It is a pan-Janus kinase (JAK) inhibitor approved for the treatment of atopic dermatitis in Japan. It functions as an EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor, an anti-inflammatory agent, an antipsoriatic, and an antiseborrheic. Delgocitinib is classified as a pyrrolopyrimidine, tertiary amino compound, nitrile, azaspiro compound, tertiary carboxamide, and N-acylazetidine.
| CAS No. | 1263774-59-9 |
|---|---|
| Product Name | Delgocitinib |
